Discussion
When I was diagnosed with immune thrombocytopenia (ITP) at 8 years old, I knew my life was changing, but I didn’t fully understand just…
The U.S. Food and Drug Administration (FDA) has granted orphan drug status — a designation that aims to speed the development of therapies for rare diseases — to the experimental oral med sovleplenib as a potential treatment for primary immune thrombocytopenia (ITP). Developer Hutchmed announced the new designation…
Latest news & perspectives
Discussion
Discussion
Regular preventive treatment with the approved infusion therapy Adzynma (ADAMTS13 recombinant-krhn) may help reduce the long-term risk of organ damage in people with congenital thrombotic…
Discussion
Terbutaline, an asthma medication, reduced abnormal immune cell activity linked to platelet destruction in laboratory studies of mouse and patient cells with immune thrombocytopenia…
